HLTF and cancer: As a result, loss of RAD18 or UBC13 in BRCA1-deficient cancer cells does not abrogate reversed replication fork degradation, which is instead rescued upon knockdown of the fork reversal translocases SMARCAL1, ZRANB3 or HLTF.